EUVIMEDEUVIMED entdecken
Crossref

Honokiol regulates ovarian cancer cell malignant behavior through YAP / TAZ pathway modulation

Fang Liu iD, Yufang Zhang, Xinyi Xia, Jing Han, Linyan Cao

Journal of Obstetrics and Gynaecology Research · 2024

DOI: 10.1111/jog.15940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2024. Verfasst von Fang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Second Affiliated Hospital of Jiaxing University, Jiaxing City, Zhejiang Province, China. Hauptthemen laut MEDLINE: Lignans, Ovarian Neoplasms, Biphenyl Compounds, YAP-Signaling Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Medical and Health Technology Programme of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian cancer (OVCA) stands as one of the most fatal gynecological malignancies. Honokiol (HNK) has been substantiated by numerous studies for its anti‐tumor activity against malignancies including OVCA. Consequently, this work was designed to elucidate the impact of HNK‐mediated modulation of the YAP/TAZ pathway on the biological functions of OVCA cells.

Methods

OVCA cells were subjected to treatment with varying concentrations (0, 25, 50, 75, and 100 μM) of HNK, concomitant with the administration of YAP agonist (XMU). Assessment of cellular viability was executed employing the CCK‐8 assay, while quantification of cellular proliferation transpired via colony formation assays. Apoptosis was ascertained using flow cytometry, and expression of apoptosis‐related proteins (caspase‐3, Bcl‐2, Bax), EMT‐related proteins (E‐cadherin, N‐cadherin), migration‐associated proteins (MMP‐2, MMP‐9), and YAP/TAZ pathway‐related proteins was evaluated by western blot. Transwell experiments were conducted to assess cellular migratory and invasive propensities. Xenograft tumor models were built to observe tumor growth (volume and weight), apoptosis was assessed by TUNEL staining, and Ki67 expression was evaluated through IHC.

Results

HNK exerted inhibitory effects on the viability and proliferative capacity of OVCA cells, elicited apoptotic responses, curtailed the migratory and invasive tendencies of cells, and downregulated the YAP/TAZ pathway. Stimulation with YAP agonist (XMU‐MP‐1) partially attenuated the impacts of HNK on OVCA cell biology. Experiments in vivo confirmed that HNK inhibited OVCA tumor growth.

Conclusion

The outcomes of this investigation conclusively established that HNK orchestrated the modulation of the YAP/TAZ pathway, thereby exerting control over the malignant phenotypic manifestations of OVCA cells. The ascertained function of HNK in restraining cellular proliferation and tumor progression provided novel evidence of its anti‐proliferative activity within OVCA cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansOvarian NeoplasmsBiphenyl CompoundsYAP-Signaling ProteinsTranscription FactorsAdaptor Proteins, Signal TransducingFemaleHumansCell Line, TumorAnimalsMiceApoptosisCell ProliferationSignal TransductionAntineoplastic Agents, PhytogenicCell MovementXenograft Model Antitumor AssaysMice, NudeTranscriptional Coactivator with PDZ-Binding Motif ProteinsAllyl CompoundsPhenols

Stichwörter der Autor:innen

YAP/TAZhonokiolinhibitmalignant behaviorovarian cancer

Substanzen

honokiolLignansBiphenyl CompoundsYAP-Signaling ProteinsTranscription FactorsYAP1 protein, humanAdaptor Proteins, Signal TransducingAntineoplastic Agents, PhytogenicWWTR1 protein, humanTranscriptional Coactivator with PDZ-Binding Motif Proteins

Autor:innen und Institutionen

  • Department of Gynecology, The Second Affiliated Hospital of Jiaxing University, Jiaxing City, Zhejiang Province, China.

ORCID-Profile: Fang Liu

Förderung

  • Medical and Health Technology Programme of Zhejiang Province

Zitieren

APA

Liu, F., Zhang, Y., Xia, X., Han, J., & Cao, L. (2024). Honokiol regulates ovarian cancer cell malignant behavior through YAP / TAZ pathway modulation. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15940

Vancouver

Liu F, Zhang Y, Xia X, Han J, Cao L. Honokiol regulates ovarian cancer cell malignant behavior through YAP / TAZ pathway modulation. Journal of Obstetrics and Gynaecology Research. 2024. doi:10.1111/jog.15940

BibTeX
@article{Liu2024,
  author = {Liu, Fang and Zhang, Yufang and Xia, Xinyi and Han, Jing and Cao, Linyan},
  title = {Honokiol regulates ovarian cancer cell malignant behavior through YAP / TAZ pathway modulation},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2024},
  doi = {10.1111/jog.15940}
}
Kostenlos starten →